当前位置: X-MOL 学术Eur. J. Heart Fail. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Head-to-head comparison of contemporary heart failure risk scores
European Journal of Heart Failure ( IF 16.9 ) Pub Date : 2021-09-24 , DOI: 10.1002/ejhf.2352
Pau Codina 1, 2 , Josep Lupón 1, 2, 3 , Andrea Borrellas 1 , Giosafat Spitaleri 1 , Germán Cediel 1, 2 , Mar Domingo 1 , Joanne Simpson 4 , Wayne C Levy 5 , Evelyn Santiago-Vacas 1, 3 , Elisabet Zamora 1, 2, 3 , David Buchaca 6 , Isaac Subirana 7 , Javier Santesmases 1, 2 , Crisanto Diez-Quevedo 1 , Maria I Troya 1 , Maria Boldo 1 , Salvador Altmir 1 , Nuria Alonso 1 , Beatriz González 1 , Carmen Rivas 1 , Julio Nuñez 3, 8, 9 , John McMurray 4 , Antoni Bayes-Genis 1, 2, 3
Affiliation  

Several heart failure (HF) web-based risk scores are currently used in clinical practice. Currently, we lack head-to-head comparison of the accuracy of risk scores. This study aimed to assess correlation and mortality prediction performance of Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC-HF) risk score, which includes clinical variables + medications; Seattle Heart Failure Model (SHFM), which includes clinical variables + treatments + analytes; PARADIGM Risk of Events and Death in the Contemporary Treatment of Heart Failure (PREDICT-HF) and Barcelona Bio-Heart Failure (BCN-Bio-HF) risk calculator, which also include biomarkers, like N-terminal pro B-type natriuretic peptide (NT-proBNP).

中文翻译:

当代心力衰竭风险评分的头对头比较

目前在临床实践中使用了几种基于网络的心力衰竭 (HF) 风险评分。目前,我们缺乏对风险评分准确性的直接比较。本研究旨在评估 Meta 分析全球组在慢性心力衰竭 (MAGGIC-HF) 风险评分中的相关性和死亡率预测性能,其中包括临床变量 + 药物;西雅图心力衰竭模型 (SHFM),包括临床变量 + 治疗 + 分析物;PARADIGM 现代心力衰竭治疗中的事件和死亡风险 (PREDICT-HF) 和巴塞罗那生物心力衰竭 (BCN-Bio-HF) 风险计算器,其中还包括生物标志物,如 N 端 B 型利钠肽前体 ( NT-proBNP)。
更新日期:2021-09-24
down
wechat
bug